VYCOR MEDICAL, INC. (VYCO) Net margin 2016–2025
VYCOR MEDICAL, INC. (VYCO) net profit margin by fiscal year — reported net income divided by reported revenue.
-3.9%FY2025 · since FY2016: -113.7% → -3.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3.9% | +2.9 pp |
| FY2024 | -6.7% | -2.0 pp |
| FY2023 | -4.8% | +28.3 pp |
| FY2022 | -33.1% | -1.8 pp |
| FY2021 | -31.3% | +40.7 pp |
| FY2020 | -72.0% | -14.9 pp |
| FY2019 | -57.2% | +34.2 pp |
| FY2018 | -91.4% | +15.3 pp |
| FY2017 | -106.6% | +7.1 pp |
| FY2016 | -113.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VYCO financial trends
VYCO RevenueVYCO Net incomeVYCO Gross profitVYCO Gross marginVYCO Operating incomeVYCO Operating marginVYCO Operating cash flowVYCO Free cash flowVYCO Capital expendituresVYCO Return on equityVYCO Stock buybacksVYCO Dividends paidVYCO Total assetsVYCO Total liabilitiesVYCO Shareholders’ equityVYCO overview →